#Repost @enecta • • • • • 👨💻🌿 . The neuroprotectant properties of #CBG in Huntington’s Disease were analysed in a study published in 2015 in PubMed. . The study was conducted on mice, divided in two categories, what the researchers demonstrated was how #cannabigerol can contribute in improving motor deficiency and preserve the striatal neurons by contrasting toxicity. . CBG would be able to contribute in the increase of the reduced levels of antioxidant defences. . For the study transgenic mice were used, which means that their genome was modified by the insertion of genes belonging to other animal species. . The transgenic mice are necessary for the realisation of model systems, useful for research of #diseases, especially genetic ones. Thanks to transgenic mice, researchers are able to develop an analysis of the pharmacological responses related to a specific #pathology. . Huntington’s disease . Huntington’s Disease is a hereditary disease of the #CentralNervousSystem which determines a degeneration of the basal ganglia and of the cerebral cortex. . Clinically it is characterized by pathological involuntary movements, severe alterations of behaviour, emotional and mood disorders as well as a progressive cognitive impairment. It can be accompanied by psychotic episodes and apathy. . The onset usually is between the ages of 30 and 50 (there also exist rare juvenile forms) and the evolution of the disease is slowly progressive and fatal after 16-20 years of the disorder. . The probability to inherit the gene of choreaticdisorders from an ill parent is a 50%, often in the same family more affected individuals #coexist. . Thanks to the discovery of the gene, in 1993, whose mutation is the cause of the disease, it is, today, possible to individuate through a genetic test who is a carrier. . 📲 read full article on wwe.enecta.com . #enecta https://www.instagram.com/p/BqstBAsB_My/?utm_source=ig_tumblr_share&igshid=n7blmva3xra6